135 (Nimodipine 30 mg)
Pill with imprint 135 is Yellow, Capsule-shape and has been identified as Nimodipine 30 mg. It is supplied by Caraco Pharmaceutical Laboratories.
Nimodipine is used in the treatment of subarachnoid hemorrhage; migraine prevention; ischemic stroke and belongs to the drug class calcium channel blocking agents. Risk cannot be ruled out during pregnancy. Nimodipine 30 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for 135
Nimodipine
- Imprint:
- 135
- Strength:
- 30 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Calcium channel blocking agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Caraco Pharmaceutical Laboratories
- Inactive Ingredients:
- glycerin
peppermint oil
water
polyethylene glycol
gelatin
D&C Yellow No. 10
titanium dioxide
ammonia
ferrosoferric oxide
butyl alcohol
isopropyl alcohol
shellac
alcohol
propylene glycol
medium-chain triglycerides
Note: Inactive ingredients may vary.
More about nimodipine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 3 Reviews – Add your own review/rating
- Drug class: calcium channel blocking agents
Consumer resources
Other brands: Nimotop, Nymalize
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
